| Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness |
90 |
| LncRNATUG1 spongesmiR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification |
60 |
| Mesenchymal stromal cell-derived exosomes attenuatemyocardial ischaemia-reperfusion injury throughmiR-182-regulated macrophage polarization |
58 |
| Vascular smooth muscle contraction in hypertension |
55 |
| Cardiovascular toxicities associated with immune checkpoint inhibitors |
54 |
| A decade of genome-wide association studies for coronary artery disease: the challenges ahead |
47 |
| Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology |
46 |
| Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study |
42 |
| Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis |
41 |
| Smooth muscle cell fate and plasticity in atherosclerosis |
37 |
| Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening |
36 |
| Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension |
30 |
| Endothelial permeability, LDL deposition, and cardiovascular risk factors-a review |
30 |
| Common risk factors for heart failure and cancer |
30 |
| Smooth muscle cell and arterial aging: basic and clinical aspects |
28 |
| Targeting the highly abundant circular RNA circSlc8a1 in cardiomyocytes attenuates pressure overload induced hypertrophy |
27 |
| Innate immunity as a target for acute cardioprotection |
27 |
| Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A |
27 |
| Novel findings in neutrophil biology and their impact on cardiovascular disease |
26 |
| Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction |
26 |
| Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling |
25 |
| ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure |
24 |
| Immune system-mediated atherosclerosis caused by deficiency of long non-coding RNA MALAT1 in ApoE(-/-)mice |
24 |
| Endothelial-mesenchymal transition in atherosclerosis |
24 |
| Circulating blood cells and extracellular vesicles in acute cardioprotection |
22 |
| From genetics to response to injury: vascular smooth muscle cells in aneurysms and dissections of the ascending aorta |
22 |
| Understanding the role of the perivascular space in cerebral small vessel disease |
21 |
| Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients |
21 |
| Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity |
21 |
| Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT interleukin 6 and hydrogen peroxide |
20 |
| Inflammation: a common contributor to cancer, aging, and cardiovascular diseasesexpanding the concept of cardio-oncology |
20 |
| Red blood cell dysfunction: a new player in cardiovascular disease |
19 |
| Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities |
19 |
| Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardiumto ischaemia and reperfusion injury |
18 |
| C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice |
18 |
| Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability |
18 |
| Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology |
18 |
| Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency |
17 |
| From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment |
17 |
| IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis |
17 |
| Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology |
17 |
| Conflicting vascular and metabolic impact of the IL-33/sST2 axis |
16 |
| The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection |
16 |
| Exploring immune checkpoints as potential therapeutic targets in atherosclerosis |
16 |
| Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts |
15 |
| Genome-wide identification of circulating-miRNA expression quantitative trait loci reveals the role of severalmiRNAs in the regulation of cardiometabolic phenotypes |
15 |
| PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages |
15 |
| Cardiac effects of SGLT2 inhibitors: the sodium hypothesis |
15 |
| Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women? |
15 |
| Interleukin 6 trans-signalling and risk of future cardiovascular events |
14 |
